Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates

Frontiers in Microbiology

Volumn 6, Issue FEB, 2015, Pages

  Charretier, Yannick ^a   Köhler, Thilo ^b   Cecchini, Tiphaine ^c,d   Bardet, Chloé ^d,e   Cherkaoui, Abdessalam ^a   Llanes, Catherine ^f   Bogaerts, Pierre ^g   Chatellier, Sonia ^d   Charrier, Jean Philippe ^d   Schrenzel, Jacques ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITÉ LYON 1   (France)

^d BIOMÉRIEUX   (France)

^e UNIVERSITY OF LIMOGES   (France)

^f Université de Franche Comté ^*  (France)

^g UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

AmpC cephalosporinase; Carbapenem resistance; Cephalosporin resistance; Multidrug efflux system; OprD porin; Pseudomonas aeruginosa; RT qPCR; SRM

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BACTERIAL RNA; BETA LACTAMASE AMPC; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORINASE; COMPLEMENTARY DNA; EFFLUX PUMP; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; MESSENGER RNA; MEXAB OPRM PUMP; MEXCD OPRJ PUMP; MEXEF OPRN PUMP; MEXXY PUMP; OPRD PORIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOLYSIS; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; OPERON; PHENOTYPE; PROCEDURES; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PROTEOMICS; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SELECTED REACTION MONITORING;

PSEUDOMONAS AERUGINOSA;

EID: 84927520071     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00081     Document Type: Article

References (45)

1. Aires, J. R., Köhler, T., Nikaido, H., and Plesiat, P. (1999). Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43, 2624-2628.
2. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403-410. doi: 10.1016/S0022-2836(05)80360-2.
3. Bisbe, J., Gatell, J. M., Puig, J., Mallolas, J., Martinez, J. A., Jimenez de Anta, M. T., et al. (1988). Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Rev. Infect. Dis. 10, 629-635. doi: 10.1093/clinids/10.3.629.
4. Cabot, G., Ocampo-Sosa, A. A., Tubau, F., Macia, M. D., Rodriguez, C., Moya, B., et al. (2011). Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob. Agents Chemother. 55, 1906-1911. doi: 10.1128/AAC.01645-10.
5. Domon, B., and Aebersold, R. (2010). Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 28, 710-721. doi: 10.1038/nbt.1661.
6. Dumas, J. L., van Delden, C., Perron, K., and Köhler, T. (2006). Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol. Lett. 254, 217-225. doi: 10.1111/j.1574-6968.2005.00008.x.
7. Duncan, M. W., Aebersold, R., and Caprioli, R. M. (2010). The pros and cons of peptide-centric proteomics. Nat. Biotechnol. 28, 659-664. doi: 10.1038/nbt0710-659.
8. Giamarellou, H., and Kanellakopoulou, K. (2008). Current therapies for pseudomonas aeruginosa. Crit. Care Clin. 24, 261-278. doi: 10.1016/j.ccc.2007.12.004.
9. Hocquet, D., Berthelot, P., Roussel-Delvallez, M., Favre, R., Jeannot, K., Bajolet, O., et al. (2007a). Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob. Agents Chemother. 51, 3531-3536. doi: 10.1128/AAC.00503-07.
10. Hocquet, D., Roussel-Delvallez, M., Cavallo, J. D., and Plesiat, P. (2007b). MexAB-OprM-and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin. Antimicrob. Agents Chemother. 51, 1582-1583. doi: 10.1128/AAC.01334-06.
11. Hosaka, M., Gotoh, N., and Nishino, T. (1995). Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJ. Antimicrob. Agents Chemother. 39, 1731-1735. doi: 10.1128/AAC.39.8.1731.
12. Jalal, S., Ciofu, O., Hoiby, N., Gotoh, N., and Wretlind, B. (2000). Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother. 44, 710-712. doi: 10.1128/AAC.44.3.710-712.2000.
13. Köhler, T., Epp, S. F., Curty, L. K., and Pechere, J. C. (1999). Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 181, 6300-6305.
14. Köhler, T., Michea-Hamzehpour, M., Henze, U., Gotoh, N., Curty, L. K., and Pechere, J. C. (1997). Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23, 345-354. doi: 10.1046/j.1365-2958.1997.2281594.x.
15. Lange, V., Picotti, P., Domon, B., and Aebersold, R. (2008). Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 4, 222. doi: 10.1038/msb.2008.61.
16. Lister, P. D., Wolter, D. J., and Hanson, N. D. (2009). Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22, 582-610. doi: 10.1128/CMR.00040-09.
17. Livermore, D. M. (1995). beta-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8, 557-584.
18. Livermore, D. M. (2002). Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34, 634-640. doi: 10.1086/338782.
19. Lyczak, J. B., Cannon, C. L., and Pier, G. B. (2000). Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes. Infect. 2, 1051-1060. doi: 10.1016/S1286-4579(00)01259-4.
20. Maclean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., et al. (2010). Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966-968. doi: 10.1093/bioinformatics/btq054.
21. Martinez-Ramos, I., Mulet, X., Moya, B., Barbier, M., Oliver, A., and Alberti, S. (2014). Overexpression of MexCD-OprJ reduces Pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing. Antimicrob. Agents Chemother. 58, 2426-2429. doi: 10.1128/AAC.02012-13.
22. Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., and Nishino, T. (2000). Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44, 3322-3327. doi: 10.1128/AAC.44.12.3322-3327.2000.
23. McAlister, G. C., Huttlin, E. L., Haas, W., Ting, L., Jedrychowski, M. P., Rogers, J. C., et al. (2012). Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. Anal. Chem. 84, 7469-7478. doi: 10.1021/ac301572t.
24. Micek, S. T., Lloyd, A. E., Ritchie, D. J., Reichley, R. M., Fraser, V. J., and Kollef, M. H. (2005). Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob. Agents Chemother. 49, 1306-1311. doi: 10.1128/AAC.49.4.1306-1311.2005.
25. Mine, T., Morita, Y., Kataoka, A., Mizushima, T., and Tsuchiya, T. (1999). Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43, 415-417.
26. Morita, Y., Tomida, J., and Kawamura, Y. (2012). MexXY multidrug efflux system of Pseudomonas aeruginosa. Front. Microbiol. 3:408. doi: 10.3389/fmicb.2012.00408.
27. Mueller-Ortiz, S. L., Drouin, S. M., and Wetsel, R. A. (2004). The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect. Immun. 72, 2899-2906. doi: 10.1128/IAI.72.5.2899-2906.2004.
28. Pfaffl, M. W., Horgan, G. W., and Dempfle, L. (2002). Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e36. doi: 10.1093/nar/30.9.e36.
29. Picotti, P., Bodenmiller, B., Mueller, L. N., Domon, B., and Aebersold, R. (2009). Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138, 795-806. doi: 10.1016/j.cell.2009.05.051.
30. Pirnay, J. P., De Vos, D., Mossialos, D., Vanderkelen, A., Cornelis, P., and Zizi, M. (2002). Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ. Microbiol. 4, 872-882. doi: 10.1046/j.1462-2920.2002.00281.x.
31. Poole, K. (2011). Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2:65. doi: 10.3389/fmicb.2011.00065.
32. Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., et al. (1996). Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21, 713-724. doi: 10.1046/j.1365-2958.1996.281397.x.
33. Poole, K., Krebes, K., McNally, C., and Neshat, S. (1993). Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175, 7363-7372.
34. Rau, M. H., Hansen, S. K., Johansen, H. K., Thomsen, L. E., Workman, C. T., Nielsen, K. F., et al. (2010). Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ. Microbiol. 12, 1643-1658.
35. Ruijter, J. M., Ramakers, C., Hoogaars, W. M., Karlen, Y., Bakker, O., van den Hoff, M. J., et al. (2009). Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 37:e45. doi: 10.1093/nar/gkp045.
36. Shilov, I. V., Seymour, S. L., Patel, A. A., Loboda, A., Tang, W. H., Keating, S. P., et al. (2007). The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell Proteomics 6, 1638-1655. doi: 10.1074/mcp.T600050-MCP200.
37. Tabb, D. L., Vega-Montoto, L., Rudnick, P. A., Variyath, A. M., Ham, A. J., Bunk, D. M., et al. (2010). Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J. Proteome. Res. 9, 761-776. doi: 10.1021/pr9006365.
38. Tiwari, V., and Tiwari, M. (2014). Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii. Front. Microbiol. 5:512. doi: 10.3389/fmicb.2014.00512.
39. Trias, J., and Nikaido, H. (1990a). Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34, 52-57.
40. Trias, J., and Nikaido, H. (1990b). Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J. Biol. Chem. 265, 15680-15684.
41. Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B. C., Remm, M., et al. (2012). Primer3-new capabilities and interfaces. Nucleic Acids Res. 40:e115. doi: 10.1093/nar/gks596.
42. Vandesompele, J., De, P. K., Pattyn, F., Poppe, B., Van Roy, N., De, P. A., et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:34. doi: 10.1186/gb-2002-3-7-research0034.
43. Vogne, C., Aires, J. R., Bailly, C., Hocquet, D., and Plesiat, P. (2004). Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 48, 1676-1680. doi: 10.1128/AAC.48.5.1676-1680.2004.
44. Wang, J., Zhou, J. Y., Qu, T. T., Shen, P., Wei, Z. Q., Yu, Y. S., et al. (2010). Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int. J. Antimicrob. Agents 35, 486-491. doi: 10.1016/j.ijantimicag.2009.12.014.
45. Worboys, J. D., Sinclair, J., Yuan, Y., and Jorgensen, C. (2014). Systematic evaluation of quantotypic peptides for targeted analysis of the human kinome. Nat. Methods 11, 1041-1044. doi: 10.1038/nmeth.3072.